Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment by Elizabeth S. Munroe, Greg A. Grandits, Robert C. Hyzy, Hallie C. Prescott, Thomas W. Barrett, Robin L. Dewar, Nicole Engen, Anna L. Goodman, Timothy J. Hatlen, Helene Highbarger, Thomas L. Holland, Gareth Hughes, Tomas O. Jensen, Muhammad A. Khan, Ioannis Kalomenidis, Nayon Kang, Sylvain Laverdure, Prasad Manian, Vidya Menon, Ravi Patel, Srikanth Ramachandruni, Tauseef Rehman, Kathryn Shaw-Saliba, Birgit Thorup Røge, David M. Vock, Amy C. Weintrob, Barnaby E. Young, Anne P. Frosch, for the STRIVE Network and Therapeutics for Inpatients with COVID-19 (TICO) study groups

Get full text

Epidemiologic Characteristics and Management of Sepsis Among Previously Healthy PatientsTake-Home Points by Rachel K. Hechtman, MD, Megan E. Heath, PhD, Jennifer K. Horowitz, MA, Elizabeth McLaughlin, MS, RN, Patricia J. Posa, RN, BSN, MSA, CCRN, John Blamoun, MD, Paul Bozyk, MD, Megan Cahill, DO, MBA, FACOEP, Rania Esteitie, MD, FCCP, ATSF, Kevin Furlong, DO, Namita Jayaprakash, MB, BcH BAO, MRCEM, Jessica Jones, PharmD, Maximiliano Tamae-Kakazu, MD, Joan Nagelkirk, MD, Thomas Pfotenhauer, DO, Derek C. Angus, MD, MPH, FRCP, Scott A. Flanders, MD, Elizabeth S. Munroe, MD, Hallie C. Prescott, MD

Get full text

Long-term anti-SARS-CoV-2 antibody trajectories after neutralizing monoclonal antibody treatment. by Elizabeth S Munroe, Greg A Grandits, Robert C Hyzy, Hallie C Prescott, Thomas W Barrett, Robin L Dewar, Nicole Engen, Anna L Goodman, Timothy J Hatlen, Helene Highbarger, Thomas L Holland, Gareth Hughes, Tomas O Jensen, Muhammad A Khan, Ioannis Kalomenidis, Nayon Kang, Sylvain Laverdure, Prasad Manian, Vidya Menon, Ravi Patel, Srikanth Ramachandruni, Tauseef Rehman, Kathryn Shaw-Saliba, Birgit Thorup Røge, David M Vock, Amy C Weintrob, Barnaby E Young, Anne P Frosch, STRIVE Network and Therapeutics for Inpatients with COVID-19 (TICO) study groups

Get full text